A Maternally Sequestered, Biopolymer‐Stabilized Vascular Endothelial Growth Factor (VEGF) Chimera for Treatment of Preeclampsia

BACKGROUND: Preeclampsia is a hypertensive syndrome that complicates 3% to 5% of pregnancies in the United States. Preeclampsia originates from an improperly vascularized and ischemic placenta that releases factors that drive systemic pathophysiology. One of these factors, soluble fms‐like tyrosine...

Descripción completa

Detalles Bibliográficos
Autores principales: Logue, Omar C., Mahdi, Fakhri, Chapman, Heather, George, Eric M., Bidwell, Gene L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2017
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5779036/
https://www.ncbi.nlm.nih.gov/pubmed/29629873
http://dx.doi.org/10.1161/JAHA.117.007216

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5779036/
https://www.ncbi.nlm.nih.gov/pubmed/29629873
http://dx.doi.org/10.1161/JAHA.117.007216

Ejemplares similares